LIST DO REDAKCJI
Palenie tytoniu – rozpowszechnienie i główne kierunki badań
1
School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec; Students’ Research Group at the Department of General and Inorganic Chemistry; Medical University of Silesia;
2
School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec; Department of General and Inorganic Chemistry; Medical University of Silesia; Head of the Department: Prof. A. Sobczak Ph.D.
3
Institute of Occupational Medicine and Environmental Health, Department of Chemical Hazards and Genetic Toxicology, Sosnowiec, Poland; Director of the Institute: P.Z. Brewczynski M.D., Ph.D.
Med Srod. 2014;17(4):7-18
SŁOWA KLUCZOWE
STRESZCZENIE
Palenie tytoniu jest przyczyną śmierci około 5 milionów ludzi rocznie na całym świecie. Wiedza na temat szkodliwego wpływu palenia na zdrowie stała się powszechna w drugiej połowie XX wieku. Jednak na przestrzeni lat przemysł tytoniowy podejmował działania mające na celu utrzymanie starych i pozyskanie nowych konsumentów. Jednym z nich było wprowadzenie na rynek papierosów o obniżonej zawartości nikotyny i substancji smolistych. W ostatnich latach na wielu światowych rynkach pojawiły się urządzenia zwane elektronicznymi papierosami. Zostały one zaprojektowane, jako produkt alternatywny do konwencjonalnych papierosów dostarczając nikotynę w formie aerozolu do organizmu
użytkownika. Cieszą się one coraz większą popularnością, na co wskazuje wysoki odsetek ich użytkowników oraz ilość ukazujących się na ich temat publikacji. Obecnie zdania są podzielone i elektroniczne papierosy mają wielu zwolenników jak i przeciwników. Przypomina to sytuację dotyczącą konwencjonalnych papierosów z XX wieku. W pracy zebrano najistotniejsze informacje na temat rozpowszechnienia palenia, jak i informacje na temat działań podejmowanych przez rządy oraz naukowców w celu ochrony zdrowia publicznego. Wiedza ta może być przydatna w nadchodzących latach ze względu na pojawiającą się szeroką gamę produktów takich jak elektroniczne papierosy, zawierających substancję uzależniającą, jaką stanowi nikotyna.
Each year smoking leads to the premature death of over 5 million people around the world. However, the tobacco industry took actions like introducing cigarettes which contain less nicotine and tar aimed at not only maintaining the old clientele, but also attracting a new one. The knowledge of the adverse health effects of smoking became widespread in the second half of the 20th century and changed attitudes towards smoking. In recent years, in many markets in the world a new device representing an alternative to tobacco products was introduced. Electronic cigarettes are designed to deliver nicotine into the respiratory system in the form of an aerosol. They have been gaining more and more popularity, as evidenced by the increase in the percentage of users as well as in the numbers of publications about them. Currently, opinions are divided and the e-cigarette has almost as many supporters as opponents. All this resembles the situation concerning conventional cigarettes in the 20th century. The aim of the study is to gather the most significant information concerning, on the one hand, the spreading popularity of tobacco smoking and, on the other, the research topics undertaken by contemporary scientists, as well as the government actions meant to protect from dangers of nicotine addiction in the 20th and 21st century. New developments of products containing this highly addictive substance call for systematic research in the interest of public health.
REFERENCJE (106)
1.
Feinhandler S., Fleming H., Monahan J.: Pre-Columbian tobaccos in the Pacific. Economic Botany 1979; 33: 213-26.
2.
Gately I.: Tobacco: The Story of how Tobacco Seduced the World. Grove/Atlantic, Incorporated 2001.
4.
Brooks J. E.: The mighty leaf: Tobacco through the centuries. Boston: Little, Brown and Company, 1953. Science Education 1954; 38(3): 245-245.
5.
Benowitz N., Alice B., Homburg et al.: “Tobacco: History of.” Encyclopedia of Drugs, Alcohol, and Addictive Behavior. 2004 [cited 2013 29.11.2013]; Available from: http://www. encyclopedia.com/doc/1G2-3403100446.html.
7.
Suzuki B.: The First English Pipe Smoker in Japan; William Adams, the Pilot and the English Trade House in Hirato 1600-1621, 1997.
8.
Milne I.: A counterblaste to tobacco: King James’s anti-smoking tract of 1616. The Journal of the Royal College of Physicians of Edinburgh 2011.
9.
Petrone G.: Tobacco Advertising: The Great Seduction. Schiffer Publishing, Limited 1996.
10.
Garfinkel L.: Trends in Cigarette Smoking in the United States. Preventive Medicine 1997; 26(4): 447-450.
11.
Roberts B.: Inventions in the tobacco industry. 2006 [cited 2013 25.05.2013]; Available from: http://www.learnnc.org/ lp/editions/nchist-newsouth/4402.
12.
Hess H.: The other prohibition: The cigarette crisis in postwar Germany. Crime, Law and Social Change 1996; 25(1): 43-61.
14.
Posselt W., Reimann L.: Chemische Untersuchungen des Tabaks und Darstellung des eigenhumlichen wirksamen Principes dieser Pflanze. Geigers Magazin der Pharmazie 1828; 24: 138-61.
15.
Roffo A.: Was Man von dem Krebs wissen muss. Auflklärungsschrift [What you should know about cancer: A popular exposition]. Instituto de Medicine Experimental: Buenos Aires 1928.
16.
Brandt A.: Cigarette Century: the Rise, Fall and Deadly Persistence of the Product that Defined America. Tob Control 2007; 16(5): 360-360.
17.
Glantz S., et al.: The Cigarette Papers. Berkeley: University of California Press 1996.
18.
Wynder E., Graham E.: Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc 1950; 143(4): 329-36.
19.
IARC. Globocan 2008. Cancer Fact Sheet: Lung Cancer Mortality Worldwide in 2008. 2011 [cited 2013 29.11.2013]; Available from: http://globocan.iarc.fr/factsh....
20.
Snegireff L., Lombard O.: Survey of Smoking Habits of Massachusetts Physicians. New England Journal of Medicine 1954; 250(24): 1042-1045.
21.
Gardner M., Brandt A.: The Doctors’ Choice Is America’s Choice. American Journal of Public Health 2006; 96(2): 222- 232.
22.
Lombard H., Doering C.: Cancer Studies in Massachusetts: Habits, Characteristics and Environment of Individuals with and without Cancer. New England Journal of Medicine 1928; 198(10): 481-487.
23.
Proctor R., Angel H.: Roffo: the forgotten father of experimental tobacco carcinogenesis. Bulletin of the World Health Organization 2006; 84: 494-496.
25.
Roffo A.: Durch Tabak beim Kaninchen entwickeltes Carcinom. Zeitschrift für Krebsforschung 1931; 33(1-2): 321-332.
26.
Roffo A.: Krebs und Sarkom durch Ultraviolett- und Sonnenstrahlen. Zeitschrift für Krebsforschung 1935; 41(1): 448- 467.
27.
Doll S.: Commentary: Lung cancer and tobacco consumption. International Journal of Epidemiology 2001; 30(1): 30-31.
28.
Hanmer H., to Hahn P.: Memorandum on alleged causative relation between cigarette smoke and bronchiogenic carcinoma. 1950; available from: http://tobaccodocuments.org. tplp.html; accessed: 29.11.2013.
29.
Schrek R. et al.: Tobacco Smoking as an Etiologic Factor in Disease. I. Cancer. Cancer Res 1950; 10(1): 49-58.
30.
Mills C.A., Porter M.: Tobacco Smoking Habits and Cancer of the Mouth and Respiratory System. Cancer Res 1950; 10(9): 539-542.
31.
Doll R., Hill A.: Smoking and carcinoma of the lung; preliminary report. Br Med J 1950; 2(4682): 739-48.
32.
Levin M., Goldstein H., Gerhardt P.: Cancer and tobacco smoking: A preliminary report. J Am Med Assoc 1950; 143(4): 336-338.
34.
Wynder E., Graham E., Croninger A.: Experimental Production of Carcinoma with Cigarette Tar. Cancer Res 1953; 13(12): 855-864.
35.
Tobacco Industry Research Committee, A frank Statement to cigarette smokers. 1954. available from:http://tobaccodocuments. org.tplp.html; accessed: 29.11.2013.
36.
Cummings K., Morley C., Hyland A.: Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking. Tob Control 2002; 11(suppl 1): i110-i117.
38.
Glantz S., Balbach E.: Tobacco war inside the California battles. 2000; available from: http://search.ebscohost.com/lo.... aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN =65741;accessed: 29.11.2013.
39.
Auerbach O. et al.: Changes in the Bronchial Epithelium in Relation to Smoking and Cancer of the Lung. New England Journal of Medicine 1957; 256(3): 97-104.
40.
Hammond E., Horn D.: Smoking and death rates; report on forty-four months of follow-up of 187,783 men. I. Total mortality. J Am Med Assoc 1958; 166(10): 1159-72.
41.
Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service., E. United Stated Department of Health, and Welfare, Editor: Washington: US Department of Health, Education, and Welfare, Public Health Service 1964.
43.
United States, Reviewing progress made toward the development and marketing of a less hazardous cigarette: hearings before the Consumer Subcommittee of the Committee on Commerce, United States Senate, Ninetieth Congress, first session. August 23, 24, and 25, 1967. Washington, D.C.: U.S. Government Printing Office 1968.
44.
Calfee J.: Cigarette Advertising, Health Information and Regulation before 1970. Bureau of Economics, Federal Trade Commission 1985.
45.
Rettig R.: Cancer crusade: the story of the National cancer act of 1971. Princeton, N.J.: Princeton University Press 1977.
47.
The health consequences of smoking. Report of the United Stated Public Health Service. United Stated Public Health Service Washington 1972.
48.
Institute N., The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of U.S. cigarettes: report of the NCI expert committee. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health 1996.
50.
Gori G.: Low-risk cigarettes: a prescription. Science 1976; 194(4271): 1243-6. Gori G., Lynch C.: Toward less hazardous cigarettes. Current advances. JAMA 1978; 240(12): 1255-9. 51.
51.
Kozlowski L. et al.: The misuse of ‘less-hazardous’ cigarettes and its detection: hole-blocking of ventilated filters. American Journal of Public Health 1980; 70(11): 1202-1203. 52.
52.
Benowttz N., et al., Smokers of Low-Yield Cigarettes Do Not Consume Less Nicotine. New England Journal of Medicine 1983; 309(3): 139-142.
53.
Office on smoking and health. The health consequences of involuntary smoking: a report of the Surgeon General 1986: Rockville, Maryland: Public Health Service.
54.
Office on Smoking and Health. The Helth Consequnces of Smoking: Nicotine Addiction: a report of the Surgeon General 1988.
56.
Hirayama T.: Non-smoking wives of heavy smokers have a higher risk of lung cancer: A study from Japan. BMJ 1981; 282: 183-185.
57.
Trichopoulos D., Kalandidi A., Sparos L., MacMahon B.: Lung cancer and passive smoking. Int J Cancer 1981; 27: 1-4.
58.
Glantz S., Parmley W.: Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation, 1991; 83(1): 1-12.
59.
Master Settlement Agreement. 1998; Available at: http://publichealthlawcenter. org/sites/default/files/resources/mastersettlement- agreement.pdf; accesed: 29.11.2013.
60.
Wald N., Nicolaides-Bouman A.: UK Smoking Statistics. 2nd edition, Oxford University Press 1991.
61.
Opinions and Lifestyle Survey, Smoking habits amongst adults, 2012. ONS, Sept. 2013; http://www.ons.gov.uk; accesed: 29.11.2013.
63.
Caponnetto P., Campagna D., Papale G. et al.: The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med. 2012 Feb; 6(1): 63-74.
64.
Etter J.: Electronic cigarettes: a survey of users. BMC Public Health. 2010 May 4; 10: 231. doi: 10.1186/1471-2458-10- 231.
65.
Grana R., Ling P.: Smoking revolution: a content analysis of electronic cigarette retail websites. Am J Prev Med 2014 Apr; 46(4): 395-403.
66.
Rooke C., Amos A.: News media representations of electronic cigarettes: an analysis of newspaper coverage in the UK and Scotland. Tob Control 2013.
67.
Dawkins L., Turner J., Roberts A. et al.: Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction 2013 Jun; 108 (6): 1115-25.
68.
Grana R., Ling, P.: Smoking revolution: a content analysis of electronic cigarette retail websites. Am J Prev Med 2014 Apr; 46(4): 395-403.
69.
Grana R., Glantz S., Ling P.: Electronic nicotine delivery systems in the hands of Hollywood. Tob Control 2011; 20(6): 425-426.
70.
(CDC), C.f.D.C.a.P., CDC Newsroom, About one in five U.S adult cigarettes smokers have tried an electronic cigarette. 2013.
71.
Council on Science and Public Health (CSAPH), A.M.A., Use of electronic cigarettes in smoking cessation programs. Report 6 (A-10), 159th Annual Meeting.
72.
Foulds J.,Veldheer S.: Commentary on Etter & Bullen (2011): could E-cigs become the ultimate nicotine maintenance device? Addiction 2011; 106(11): 2029-30.
73.
Barbeau A., Burda J., Siegel M.: Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract 2013; 8(1): 5.
74.
Polosa R. et al.: Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011; 11: 786.
75.
Caponnetto P. et al.: EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013; 8(6): e66317.
76.
Caponnetto P. et al.: Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 2013; 10(2): 446-61.
77.
Pepper J.K., et al.: Adolescent males’ awareness of and willingness to try electronic cigarettes. J Adolesc Health 2013; 52(2): 144-50.
78.
Choi K. et al.: Young adults’ favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: findings from a focus group study. Am J Public Health 2012; 102(11): 2088-93.
79.
Goniewicz M., Zielinska-Danch W.: Electronic cigarette use among teenagers and young adults in Poland. Pediatrics 2012; 130(4): e879-85.
80.
Trehy M., Ye W., Hadwiger M. et al.: Analysis of electronic cigarette cartridges, refill solutions and smoke for nicotine and nicotine related impurities. Journal of Liquid Chromatography & Related Technologies 2011; 34: 1442-1458.
81.
World Health Organization (WHO). WHO Study Group on Tobacco Product Regulation report on the scientific basis of tobacco product regulation WHO Technical Report Series 955. WHO, Geneva 2009.
82.
Woodcock J.: Letterto Mr. Matt Salmon President, Electronic Cigarette Association 2013. Available at: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ UCM225263.pdf, accesed: 29.11.2013.
83.
Cahn Z., Siegel M.: Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? Public Health Policy 2011; 32: 16-31. doi: 10.1057/jphp.2010.41.
84.
Cobb N., Abrams D., E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med 2011; 365: 193-5. 85.
85.
Westenberger B.: Evaluation of e-Cigarettes. St. Louis, MO: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis 2009. Available at: http://www.fda.gov/downloads/d... UCM173250.pdf ; accessed: 7.05.2014.
86.
US Food and Drug Administration: Final Report on FDA Analyses 2009 http://www.fda.gov/downloads/D... UCM173250.pdf.
87.
Wieslander G., Norback D., Lindgren T.: Experimental exposure to propy lene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001; 58: 649-655.
88.
Moline J., Golden A., Highland J. et al., Health effects evaluation of theatrical smoke, haze and pyrotechnics Report to Equity-League Pension and Health Trust Funds. 2000.
89.
Choi H., Schmidbauer N., Sundell J. et al.: Common household chemicals and the allergy risks in pre-school age children. PLoS One 2010; 5: e13423. doi:10.1371/journal. pone.0013423.
90.
Laugesen M.: Safety report on the Ruyan® e-cigarette cartridge and inhaled aerosol . Edited by Health New Zealand Ltd. 2008. www.healthnz.co.nz; accesed: 29.11.2013.
91.
Goniewicz M.L., Kuma T., Gawron M. et al.: Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013; 15: 15866.
92.
Cameron J., Howell D., White J. et al.: Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control 2013. doi:10.1136/tobaccocontrol-2012- 050604.
93.
Hadwiger M., Trehy M., Ye W. et al.: Identification of amino in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J ChromatogrA 2010; 1217: 7547–55.
94.
Uchiyama, S., Ohta K., Inaba Y. et al.: Determination of carbonyl compounds generated from the E-cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci 2013; 29(12): 1219-22.
95.
Goniewicz M.L., Knysak J., Kosmider L. et al.: Assessment of electronic cigarettes as a source of exposure to acrolein. Presentation at the Society for Research on Nicotine and Tobacco (SRNT) conference, March 2013, Boston.
96.
Williams M., Villarreal A., Bozhilov K. et al.: Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013; 8: 3.
97.
International Agency for Research on Cancer (IARC) (2013) Agents clas sified by the IARC monographs, Volumes 1-107. Last update on 4 Octo ber 2013, http://monographs.iarc.fr/ ENG/Classification/index.php.
98.
Bahl V., Lin S., Xu N.et al.: Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012; 34: 529-37.
99.
Romagna G., Allifranchini E., Bocchietto E. et al.: Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (Clear Stream-LIFE): comparison with tobacco cigarette smoke extract. InhalToxicol 2013; 25: 354-61.
100.
Flouris A., Poulianiti K., Chorti A. et al.: Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 2012; 50: 36003.
101.
TNS Opinion & Social. Attitudes of Europeans towards Tobacco. Special Eurobarometer 385, Wave EB77.1 commissioned by the Directorate General Health and Consumers of the European Commission, Brussels; 2012.
102.
Dockrell M., Morrison, R., Bauld, L. et al.: E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res. 2013.
103.
Tobacco Products Directive (2014/40/EU) http://ec. europa.eu/health/tobacco/products/revision/index_en.htm19.
104.
Office of the Surgeon General (US); Office on Smoking and Health (US). The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2004. Available from: http://www.ncbi.nlm.nih.gov/bo... accessed: 6.07.2014.
105.
WHO report on the global tobacco epidemic, 2008: The MPOWER package. Population and Development Review 2008; 34(3): 581-581.
106.
Benowitz N.: Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc 2014; 11(2): 231-5.
Udostępnij
ARTYKUŁ POWIĄZANY
| eISSN: | 2084-6312 |
| ISSN: | 1505-7054 |
Przetwarzamy dane osobowe zbierane podczas odwiedzania serwisu. Realizacja funkcji pozyskiwania informacji o użytkownikach i ich zachowaniu odbywa się poprzez dobrowolnie wprowadzone w formularzach informacje oraz zapisywanie w urządzeniach końcowych plików cookies (tzw. ciasteczka). Dane, w tym pliki cookies, wykorzystywane są w celu realizacji usług, zapewnienia wygodnego korzystania ze strony oraz w celu monitorowania ruchu zgodnie z Polityką prywatności. Dane są także zbierane i przetwarzane przez narzędzie Google Analytics (więcej).
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
